Introduction/Overview The management of fungal infections represents a significant and growing challenge in clinical medicine. The increasing prevalence of invasive mycoses is driven by several factors, including a rise in the number of immunocompromised patients due to chemotherapy, organ transplantation, and the human immunodeficiency virus (HIV) epidemic, as well as the widespread use of broad-spectrum … Read more
Introduction/Overview Leprosy, also known as Hansen’s disease, is a chronic infectious disease caused by the obligate intracellular bacillus Mycobacterium leprae. The pharmacology of antileprotic drugs constitutes a specialized domain within antimicrobial chemotherapy, focused on the eradication of this slow-growing pathogen and the management of its complex immunopathological sequelae. The clinical relevance of these agents extends … Read more
Introduction/Overview Leprosy, also known as Hansen’s disease, is a chronic granulomatous infection caused by the obligate intracellular bacillus Mycobacterium leprae. The pharmacology of antileprotic drugs constitutes a specialized domain within antimicrobial chemotherapy, focused on the eradication of this slow-growing pathogen and the management of its complex immunopathological sequelae. The introduction of the World Health Organization … Read more
Introduction/Overview Tuberculosis remains a significant global health challenge, with an estimated 10 million new cases and 1.3 million deaths reported annually. The pharmacological management of tuberculosis is complex, requiring prolonged multidrug regimens to achieve cure and prevent the emergence of drug resistance. The unique pathophysiology of Mycobacterium tuberculosis, characterized by its slow replication rate, ability … Read more
Introduction/Overview Tuberculosis (TB) remains a major global health challenge, ranking among the leading causes of death from a single infectious agent. The pharmacology of antitubercular drugs constitutes a cornerstone of infectious disease therapeutics, characterized by unique principles such as prolonged combination therapy, the management of drug resistance, and the handling of complex pharmacokinetic and toxicological … Read more
Introduction/Overview The tetracyclines and chloramphenicol represent two distinct but historically significant classes of broad-spectrum, bacteriostatic antibiotics. Their discovery in the mid-20th century marked a pivotal advancement in antimicrobial chemotherapy, providing effective tools against a wide array of pathogens, including intracellular organisms. While their clinical use has been circumscribed over time by the emergence of resistance … Read more
Introduction/Overview Aminoglycosides represent a class of potent, concentration-dependent bactericidal antibiotics derived from various species of Streptomyces and Micromonospora. Since the discovery of streptomycin in the 1940s, these agents have maintained a critical, albeit more targeted, role in modern antimicrobial therapy. Their clinical importance stems from a reliable and rapid bactericidal effect against a spectrum of … Read more
Introduction/Overview Aminoglycosides represent a class of bactericidal antibiotics derived from various species of Streptomyces and Micromonospora. These agents have maintained a crucial, albeit more targeted, role in modern antimicrobial therapy since the discovery of streptomycin in the 1940s. Their potent activity against aerobic Gram-negative bacilli and certain Gram-positive organisms ensures their continued use despite a … Read more
Introduction/Overview Macrolide antibiotics constitute a significant class of antimicrobial agents characterized by a macrocyclic lactone ring. Since the discovery of erythromycin in 1952, these compounds have served as essential therapeutic tools in the management of a diverse spectrum of bacterial infections. Their clinical importance is underscored by their activity against atypical pathogens, utility in patients … Read more
Introduction/Overview The quinolone and fluoroquinolone class of synthetic antimicrobial agents represents a cornerstone of modern antibacterial chemotherapy. Originating from the discovery of nalidixic acid in the 1960s, subsequent structural modifications have yielded broad-spectrum agents with potent activity against a wide range of Gram-negative, Gram-positive, and atypical pathogens. The clinical importance of these agents stems from … Read more